Pharmacology of signaling pathways: In type 2 diabetes

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 7, Issue 3, 2013, Pages 180-185

  Meerza, Dilnasheen ^a   Naseem, Imrana ^a   Ahmed, Jamal ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; EXENDIN 4; FATTY ACID; INSULIN; INSULIN RECEPTOR; LEPTIN; LIRAGLUTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; RESISTIN; SITAGLIPTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VILDAGLIPTIN;

ADIPOCYTE; CENTRAL NERVOUS SYSTEM; DRUG HALF LIFE; ENERGY BALANCE; ENZYME ACTIVATION; FATTY ACID OXIDATION; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE TRANSPORT; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; LIPID METABOLISM; LIPOLYSIS; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION PROFILING; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; MALE; MUSCLE, SKELETAL; OBESITY; SIGNAL TRANSDUCTION;

EID: 84882257886     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2013.06.006     Document Type: Review

References (91)

1. K.T. Brajendra, and K.S. Arvind Med Sci Monit 12 2006 130 147
2. S.E. Kahn The importance of b-cell failure in the development and progression of type 2 diabetes J Clin Endocrinol Metab 86 2013 4047 4058
3. S.S. Fajans, G.I. Bell, and K.S. Polonsky Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young N Engl J Med 345 2001 971 980
4. K.M. Utzschneider Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses Diabetes Care 29 2006 356 362
5. E.A. Davis, A. Cuesta-Munoz, and M. Raoul Mutants of glucokinase cause hypoglycaemia and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis Diabetologia 42 1999 1175 1186
6. F.M. Matschinsky, B. Glaser, and M.A. Magnuson Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities Diabetes 47 1998 307 315
7. I.D. Dukes, M.S. McIntyre, and R.J. Mertz Dependence on NADH produced during glycolysis for beta-cell glucose signaling J Biol Chem 269 1994 10979 10982
8. A. Pick, J. Clark, and P. Kubstrup Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat Diabetes 47 1998 358 364
9. B.N. Cockburn, D.M. Ostrega, and J. Sturis Changes in pancreatic islet glucokinase and hexokinase activities with increasing age, obesity, and the onset of diabetes Diabetes 46 1997 1434 1439
10. M.K. Cavaghan, D.A. Ehrmann, and K.S. Polonsky Interactions between insulin resistance and insulin secretion in the development of glucose intolerance J Clin Invest 106 2000 329 333
11. V. Saini Molecular mechanisms of insulin resistance in type 2 diabetes mellitus World J Diabetes 3 2010 68 75
12. B.J. Goldstein Insulin resistance as the core defect in type 2 diabetes mellitus Am J Cardiol 90 2002 3 10
13. I. Koichi, A. Takuya, and K. Shigehiro Obesity and Insulin Resistance Prog Med 23 2003 35 39
14. E. Steven Kahn, H.L. Rebecca, and K.M. Utzschneider Mechanisms linking obesity to insulin resistance and type 2 diabetes Nature 444 2006 14
15. K. Hida, J. Wada, and J. Eguchi Visceral adipose tissue-derived serine protease inhibitor: a unique insulin sensitizing adipocytokine in obesity Proc Natl Acad Sci USA 102 2005 10610 10615
16. G. Boden, and G.I. Shulman Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction Eur J Clin Invest 32 2002 14 23
17. G. Boden, and I. Gerald Shulman Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes Exp Clin Endocrinol Diabetes 111 2003 121 124
18. P.J. Randle, P.B. Garland, C.N. Hales, and E.A. Newsholme The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus Lancet 21 1963 785 789
19. J.D. McGarry Glucose-fatty acid interactions in health and disease Am J Clin Nutr 67 1998 500S 504S
20. J.D. McGarry Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership Biochem Soc Trans 23 1995 481 485
21. S.T. Swanson, D.W. Foster, J.D. McGarry, and N.F. Brown Roles of the N- and C-terminal domains of carnitine palmitoyltransferase I isoforms in malonyl-CoA sensitivity of the enzymes: insights from expression of chimaeric proteins and mutation of conserved histidine residues Biochem J 335 1998 513 519
22. N.B. Ruderman, A.K. Saha, D. Vavvas, and L.A. Witters Malonyl-CoA, fuel sensing, and insulin resistance Am J Physiol 276 1999 E1 E18
23. I. Nieto-Vazquez, S. Fernández-Veledo, D.K. Krämer, R. Vila-Bedmar, L. Garcia-Guerra, and M. Lorenzo Insulin resistance associated to obesity: the link TNF-alpha Arch Physiol Biochem 114 2008 183 194
24. B.E. Stephen The role of TNF-α in insulin resistance Endocrine 23 2004 177 182
25. Y. Hannun, and L.M. Obeid Ceramide: an intracellular signal for apoptosis Trends Biochem Sci 120 1995 73 77
26. R. Kolesnick, and D.W. Golde The sphingomylin pathway in tumor necrosis factor and interleukin-1 signalling Cell 77 1994 325 328
27. S. Schutze, T. Machleidt, and M. Kronke The role of diacyglycerol and ceramide in tumor necrosis factor and interleukin-1 signal transduction J Leukocute Biol 56 1994 533 541
28. C. Grunfeld, and K.R. Feingold The metabolic effects of tumor necrosis factor and other cytokines Biotherapy 3 1991 143 158
29. K. Rabe, M. Lehrke, G. Klaus Parhofer, and C. Uli Broedl Adipokines and insulin resistance Mol Med 14 2008 741 751
30. P. Arner Insulin resistance in type 2 diabetes - role of the adipokines Curr Mol Med 5 2005 333 339
31. P.A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance Am J Physiol Endocrinol Metab 280 2001 E745 E751
32. B. Beutler TNF, immunity and inflammatory disease: lessons of the past decade J Invest Med 43 1995 227 248
33. M. Grell, E. Douni, and H. Wajant The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor Cell 83 1995 793 802
34. H. Ruan, and F. Harvey Lodish Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α Cytokine Growth Factor Rev 14 2003 447 455
35. A.G. Pittas, N.A. Joseph, and A.S. Greenberg Adipocytokines and insulin resistance J Clin Endocrinol Metab 89 2004 447 452
36. I.M. Liu, F.L. Hsu, C.F. Chen, and J.T. Cheng Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats Br J Pharmacol 129 2000 631 636
37. J. Steinberger, L. Steffen, JacobsF D.R. Jr., A. Moran, C.-P. Hong, and A.R. Sinaiko Relation of leptin to insulin resistance syndrome in children Obes Res 11 2003 1124 1130
38. Y. Toyoshima, O. Gavrilova, S. Yakar, W. Jou, S. Pack, Z. Asghar, M.B. Wheeler, and Leroith Derek Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes Endocrinology 146 2005 4024 4035
39. R.S. Ahima, and J. Flier Leptin Annu Rev Physiol 62 2000 413 437
40. R.S. Ahima, D. Prabakaran, C. Mantzoros, D. Qu, B.B. Lowell, and E. Maratos-Flier Role of leptin in the neuroendocrine response to fasting Nature 382 1996 250 252
41. Florencia Ziemke, and C.S. Mantzoros Adiponectin in insulin resistance: lessons from translational research Am J Clin Nutr 91 2010 258S 261S
42. M. Haluzík, J. Pařízková, and M.M. Haluzík Adiponectin and its role in the obesity-induced insulin resistance and related complications Physiol Res 53 2004 123 129
43. T. Yamauchi, J. Kamon, and H. Waki The fat derived vitamin adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7 2001 941 946
44. A.J. Scheen, N. Finer, P. Hollander, M.D. Jensen, and L.F. Van Gaal Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomized controlled study Lancet 368 2006 1660 1672
45. M. Stumvoll, and H. Haring Resistin and adiponectin of mice and men Obes Res 10 2002 1197 1199
46. J.L. Chiasson, J.E. Liljenquist, F.E. Finger, and W.W. Lacy Differential sensitivity of glycogenolysis and gluconeogenesis to insulin infusions in dogs Diabetes 25 1976 283 291
47. L. Rossetti, A. Giaccari, and N. Barzilai Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats: implications for the pathophysiology of fasting hyperglycemia in diabetes J Clin Invest 92 1993 1126 1134
48. R. Gasa, P.B. Jansen, and H.K. Berman Distinctive regulatory and metabolic properties of glycogen-targeting subunits of protein phosphatase-1 (PTG, GL, GM/RGl) expressed in hepatocytes J Biol Chem 275 2000 26396 26403
49. C.B. Newgard, M.J. Brady, R.M. O'Doherty, and A.R. Saltiel Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1 Diabetes 49 2000 1967 1977
50. D. Yeagley, S. Guo, T. Unterman, and P.G. Quinn Gene- and activation-specific mechanisms for insulin inhibition of basal and glucocorticoid-induced insulin-like growth factor binding protein-1 and phosphoenolpyruvate carboxykinase transcription: roles of forkhead and insulin response sequences J Biol Chem 276 2001 33705 33710
51. J.G. Jackson, J.I. Kreisberg, and A.P. Koterba Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells Oncogene 19 2000 4574 4581
52. R.K. Hall, T. Yamasaki, and T. Kucera Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin: the role of winged helix/forkhead proteins J Biol Chem 275 2000 30169 30175
53. C. Wolfrum, E. Asilmaz, and E. Luca Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes Nature 4327 2004 1027 1032
54. X. Chen, N. Iqbal, and G. Boden The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects J Clin Invest 103 1999 365 372
55. I. Magnusson, D.L. Rothman, and D.P. Gerard Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration Diabetes 44 1995 185 189
56. I. Magnusson, D.L. Rothman, and L.D. Katz Increased rate of gluconeogenesis in type II diabetes mellitus: a 13C nuclear magnetic resonance study J Clin Invest 90 1992 1323 1327
57. M.W. Schwartz, S.C. Woods, and D. Porte Jr. Central nervous system control of food intake Nature 404 2000 661 671
58. J.C. Bruning, D. Gautam, and D.J. Burks Role of brain insulin receptor in control of body weight and reproduction Science 289 2000 2122 2125
59. S. Obici, Z. Feng, and G. Karkanias Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats Nat Neurosci 5 2002 566 572
60. J.K. Elmquist, and J.N. Marcus Rethinking the central causes of diabetes Nat Med 9 2003 645 647
61. W. Fan, D.M. Dinulescu, and A.A. Butler The central melanocortin system can directly regulate serum insulin levels Endocrinology 141 2000 3072 3079
62. S. Obici, Z. Feng, and A. Arduini Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production Nat Med 9 2003 756 761
63. M.W. Schwartz Progress in the search for neuronal mechanisms coupling type 2 diabetes to obesity J Clin Invest 108 2001 963 964
64. Y. Leng, K.R. Hakan Karlsson, and R. Juleen Zierath Insulin signaling defects in type 2 diabetes Rev Endocr Metab Disord 5 2004 111 117
65. J.R. Zierath, and H. Wallberg-Henriksson From receptor to effector: insulin signal transduction in skeletal muscle from type II diabetic patients Ann NY Acad Sci 967 2002 120 134
66. J.R. Zierath, A. Krook, and H. Wallberg-Henriksson Insulin action and insulin resistance in human skeletal muscle Diabetologia 43 2000 821 835
67. J. Avruch Insulin signal transduction through protein kinase cascades Mol Cell Biochem 182 1998 31 48
68. A.G. Danielsen, F. Liu, Y. Hosomi, K. Shii, and R.A. Roth Activation of protein kinase C inhibits signaling by members of the insulin receptor family J Biol Chem 37 1995 21600 21605
69. A.D. Kohn, K.S. Kovacina, and R.A. Roth Insulin stimulates the kinase activity of Rac-Pk, a pleckstrin homology domain containing ser/thr kinase Embo J 14 1995 4288 4295
70. P.R. Shepherd, D.J. Withers, and K. Siddle Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling Biochem J 333 1998 471 490
71. B. Cheatham Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation Mol Cell Biol 14 1994 4902 4911
72. S.K. Moule, G.I. Welsh, N.J. Edgell, N.J. Foulstone, C.G. Proud, and R.M. Denton Regulation of protein kinase B and glycogen synthase kinase-3 by insulin and beta-adrenergic agonists in rat epididymal fat cells, Activation of protein kinase B by wortmannin-sensitive and insensitive mechanisms J. Biol Chem 272 1997 7713 7719
73. T. Okada, Y. Kawano, T. Sakakibara, O. Hazeki, and M. Ui Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes, Studies with a selective inhibitor wortmannin J Biol Chem 269 1994 3568 3573
74. Y. Le Marchand-Brustel, N. Gautier, M. Cormont, and E. Van Obberghen Wortmannin inhibits the action of insulin but not that of okadaic acid in skeletal muscle: comparison with fat cells Endocrinology 136 1995 3564 3570
75. P.R. Shepherd, B.T. Nave, and K. Siddle Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase Biochem J 305 1995 25 28
76. T. Okada, Y. Kawano, T. Sakakibara, O. Hazeki, and M. Ui Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes, Studies with a selective inhibitor wortmannin J Biol Chem 269 1994 3568 3573
77. K. Hara 1-phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells Proc Natl Acad Sci USA 91 1994 7415 7419
78. R. Mendez, M. Myers Jr., M.F. White, and R.E. Rhoads Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase Mol Cell Biol 16 1996 2857 2864
79. E. Tsiani, E. Bogdanovic, A. Sorisky, L. Nagy, and I.G. Fantus Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C Diabetes 47 1998 1676 1686
80. E. Bernal-Mizrachi, S. Fatrai, J.D. Johnson, M. Ohsugi, and K. Otani Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet β cells J Clin Invest 114 2004 928 936
81. L.M. Dickson, and C.J. Rhodes Pancreatic β-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt? Am J Physiol Endocrinol Metab 287 2004 E192 E198
82. S.A. Summers, and M.J. Birnbaum A role for the serine/threonine kinase, Akt, in insulin-stimulated glucose uptake Biochem Soc Trans 25 1997 981 988
83. J.T.J.R. Brozinick, and M.J. Birnbaum Insulin, but not contraction, activates Akt/pkb in isolated rat skeletal muscle J Biol Chem 273 1998 14679 14682
84. L.N. Cong, H. Chen, Y. Li, L. Zhou, M. Mcgibbon, S. Taylor, and M. Quon Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose Cells Mol Endocrinol 11 1997 1881 1890
85. R.Z. Yang, M.J. Lee, and H. Hu Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action Am J Physiol 290 2006 E1253 E1261
86. J.F. Tant, S. Grillo, T. Gremeaux, P.J. Coffer, E. Van obberghen, and L.Y. Marchand-brustel Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes Endocrinology 138 1997 2005 2010
87. K.R. Ueki, K.Y. Yamamoto-Honda, T. Yamauchi, K. Tobe, B.M.T. Burgering, P.J. Coffer, I. Komuro, Y. Akanuma, Y. Yazaki, and T. Kadowaki Potential role of proteinkinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis J Biol Chem 273 1998 5315 5322
88. D.A. Cross, D.R. Alessi, P. Cohen, M. Andjelkovich, and B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785 789
89. T.A. Kupriyanova, and K.V. Kandror Akt-2 binds to GLUT4-containing vesicles and phosphorylates their component proteins in response to insulin J Biol Chem 274 1999 1458 1464
90. K. Dungan, and J.B. Buse Glucagon-like peptide 1-based therapies for type 2 diabetes: a focus on exenatide Clin Diabetes 23 2005 56 62
91. B. John, R. Julio, and S. Giorgio Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) The Lancet 374 2009 39 47